A research team from Utrecht University (Netherlands), Erasmus Medical Centre and the company Harbour BioMed (HBM) has published an article in Nature in which they state that they have identified antibodies that neutralize the SARS-CoV-2 virus in a laboratory setting, and which they think could play a role in treating the COVID-19 disease
Link to article: https://www.nature.com/articles/s41467-020-16256-y
The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted therapeutics for treatment of this disease are currently lacking. Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV) in cell culture. This cross-neutralizing antibody targets a communal epitope on these viruses and may offer potential for prevention and treatment of COVID-19.